Japan supplies 5 of 20 XPRIZE Healthspan finalists, Jamie Justice says

A quarter of the finalists in the $101M XPRIZE Healthspan come from a single asian country. Of the 20 teams still in the race to prove that human aging can be reversed, 5 are from Japan. Jamie Justice, who runs the competition, explains what she sees behind that number, and why it may say as much about national commitment as it does about the science. Japan is living through what the rest of the developed world is about to face: a rapidly aging population, with all the joys and the consequences that come with it. It has responded by making longevity a national priority. In this 5-minute excerpt, Jamie talks about what that commitment looks like from inside a competition that measures every team against the same standard, with real money on the line. For context, the 2025 Innovation Landscape Report put the overall team pool at 55% North America, 28% Asia and 13% Europe. Japan's share of the finalists stands out even against that. Watch the full conversation with Jamie, including which of the three proof domains (muscle, cognition, immune function) are moving fastest, the measurement problem underneath the prize, and the collaboration happening between competing teams: ▶ https://www.youtube.com/watch?v=CHuSuqE179k ── RESOURCES ── XPRIZE Healthspan: https://www.xprize.org/prizes/healthspan The 20 finalist teams: https://www.xprize.org/news/20-healthspan-finalist-teams-advance-in-the-race-to-extend-healthy-aging My first conversation with Jamie, February 2025: https://www.youtube.com/watch?v=0amxHvcDV6o ── GUEST ── Jamie Justice, PhD — EVP, XPRIZE Healthspan. Gerontologist and clinical trialist. Her work centers on translating geroscience into measurable clinical outcomes. ── ABOUT THIS CHANNEL ── Tom Nodine is the founder of Human Life Expectancy and author of "Revolutionizing Insurance with Epigenetic Testing." This channel covers what is actually changing human life expectancy — biological age measurement, longevity interventions, and the economics of who pays for them. https://www.humanlifeexpectancy.com Subscribe for more conversations with the researchers doing this work. Human Life Expectancy Inc. helps insurers, reinsurers, and employers use epigenetic testing and biological age to price risk better and help their customers live longer, healthier lives. Work with us: humanlifeexpectancy.com Tom on LinkedIn: https://www.linkedin.com/in/tnodine/ Book: Revolutionizing Insurance with Epigenetic Testing — https://www.amazon.com/dp/B0DHV41W2L DISCLOSURES Tom Nodine is CEO of Human Life Expectancy Inc., which has commercial interests in epigenetic testing. Guests may have their own commercial or research interests; these are noted in-video where relevant. #longevity #XPRIZE #healthspan #Japan #aging